Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Orpha Biotech
Orpha Biotech develops innovative small molecules to treat rare diseases like systemic sclerosis and juvenile rheumatoid arthritis.
Sector
Subsector
Location
total rounds
total raised
Virometix
Virometix develops vaccines and immunotherapeutic drugs for infectious and chronic diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Soligenix
Soligenix is a biotechnology company focused on treating rare diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Chimerix
Chimerix is a biopharmaceutical company that develops novel antiviral therapeutics to improve patient care in various medical settings.
Sector
Subsector
Keywords
Location
total rounds
total raised
M&A Details1
Transaction name
Acquired by
Johnson & Johnson
announced date
price
Financials
Funding Rounds4
Number of Funding Rounds
Money Raised
Their latest funding was raised on 07.04.2014. Their latest investor Roche Venture Fund. Their latest round Series B
Novo Holdings
Novo Holdings is a life science investor focused on growing investment assets for scientific, social, and humanitarian purposes.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Novo Ventures
Novo A/S manages financial assets for Novo Nordisk Foundation and invests in life science sector.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Novartis Venture Fund
Novartis Venture Fund is a private equity and venture capital arm of Novartis AG.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors5
Number of lead investors
Number of investors
Roche Venture Fund
Roche Venture Fund invests in and developing innovative life science companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Carole Nuechterlein
Ms. Carole L. Nuechterlein serves as a Head at Roche Venture Fund. Ms. Nuechterlein served as a Senior Vice President at SangStat since 2001. She joined the SangStat in October 1998 as Vice President & General Counsel. She served at Roche Bioscience as Director of Legal Affairs. Ms. Nuechterlein also worked at Syntex Corporation prior to its acquisition by Roche Holding Ltd. in 1994. As Director of Legal Affairs, Ms. Nuechterlein specialized in transactional work, representing Roche in several divestitures of Syntex assets and in the negotiation of a number of research collaboration and licensing agreements. Prior to that, she was in the San Francisco office of Skadden Arps Slate Meagher & Flom, specializing in mergers and acquisitions. She served as a Director of Alios Biopharma, Inc. Ms. Nuechterlein holds her undergraduate degree from Valparaiso University (with honors) and her J.D. from the University of Michigan (with honors).
current job
Novo Ventures
Novo A/S manages financial assets for Novo Nordisk Foundation and invests in life science sector.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Heath Lukatch
Heath Lukatch is a Founder & Managing Partner at Red Tree Venture Capital.Heath attended University of California and Stanford university.
current job
Novartis Venture Fund
Novartis Venture Fund is a private equity and venture capital arm of Novartis AG.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Campbell Murray
current job
People
Founders3
Leonid Beigelman
Leonid Beigelman is the Cheif Scientific Officer at Alios BioPharma.
current job
organization founded
Leonid Beigelman
Lawrence Blatt
Lawrence M. Blatt is the chief executive officer of Aligos Therapeutics. Lawrence M. Blatt attended University of La Verne.
current job
organization founded
Lawrence Blatt